CN Patent

CN105566303A — 达卡他韦新晶型及其制备方法

Assigned to SHANGHAI FOREFRONT PHARMA · Expires 2016-05-11 · 10y expired

What this patent protects

本发明提供了达卡他韦新晶型及其制备方法，具体地，本发明披露了结晶性的达卡他韦的双对甲苯磺酸盐、双磷酸盐和双氢溴酸盐，所述的新晶型具备较好的理化性质，有利于达卡他韦的质量控制和制剂应用。

USPTO Abstract

本发明提供了达卡他韦新晶型及其制备方法，具体地，本发明披露了结晶性的达卡他韦的双对甲苯磺酸盐、双磷酸盐和双氢溴酸盐，所述的新晶型具备较好的理化性质，有利于达卡他韦的质量控制和制剂应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN105566303A
Jurisdiction
CN
Classification
—
Expires
2016-05-11
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI FOREFRONT PHARMA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.